Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

29.67
+0.98003.42%
Post-market: 29.670.00000.00%16:10 EDT
Volume:177.63K
Turnover:5.26M
Market Cap:45.05M
PE:- -
High:30.80
Open:28.57
Low:28.23
Close:28.69
52wk High:152.22
52wk Low:11.52
Shares:1.52M
Float Shares:1.52M
Volume Ratio:1.16
T/O Rate:11.70%
Dividend:3.85
Dividend Rate:12.97%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Jun 25

Tempus AI Launches Angiosarcoma Research Collaboration with Angiosarcoma Awareness

Reuters
·
Jun 25

Anthropic’S Mythos Model Uncovers US Intelligence Vulnerabilities Within Hours; Demonstrates Potent Cyber Defense And Offense Capabilities

AI Industry Frontlines
·
Jun 24

BofA Warns: AI Bubble Flashes Historic Danger Signals

AI Industry Frontlines
·
Jun 22

Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?

Simply Wall St.
·
Jun 21

Tempus AI says multi-center study validates FDA-cleared ECG model predicting 1-year atrial fibrillation risk

Reuters
·
Jun 11

Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results

Reuters
·
Jun 09

If AI Healthcare Wins Big These Three Stocks Could Matter

Simply Wall St.
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Is Tempus AI’s (TEM) New Oncology Tools Quietly Redefining Its Precision Medicine Moat?

Simply Wall St.
·
Jun 06

Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350

Reuters
·
Jun 04

Tempus AI launches open-source digital pathology consortium

TIPRANKS
·
Jun 03

Tempus AI assumed with a Peer Perform at Wolfe Research

TIPRANKS
·
Jun 02

Tempus AI announced the upcoming clinical availability of xH

TIPRANKS
·
Jun 01

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS
·
Jun 01

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Dow Jones
·
Jun 01

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)

TIPRANKS
·
Jun 01

Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development

MT Newswires Live
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01